Diagnosis

Polycystic kidney disease

Hereditary disease characterized by gradually enlarging benign bilateral cysts of the kidney which lead to reduced renal functioning and renal failure

Also known as: ADPKD, ARPKD, Autosomal dominant polycystic kidney disease, Autosomal recessive polycystic kidney disease

Etiology

Cause [3et]

Pathophysiology [3et]

  1. Abnormal cell growth that cause ballooning of the tubule in a nephron leading to cyst formation

  2. Cyst formation can occur in proximal and distal tubules but is most common in the distal nephron and collecting duct

  3. The cyst enlarges due to fluid secretion into the cyst and destroying nearby renal tissue and promote renal fibrosis

  4. Clinical presentation:

    • Pain

    • Cyst infection

    • Cyst bleeding

    • Kidney failure

  5. Increased risk for developing Intracranial aneurysm, liver cysts, heart valve disease and abdominal hernias

Complications [3et]

Epidemiology

Incidence per 100.000 [gww][etp][esd][bof][ys3]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Fever, Headache, Hematuria, Hypertension, Polyuria

Clinical findings

Elevated Creatinine, Proteinuria, Renal cyst

Anamneses

None listed.

Localized findings

Pain
Radiates
Right flankLeft flankGeneral
Onset
Subacute (hours)Gradual (days)
Pattern
Constant
Quality
Dull
Severity
Mild (1-3)Moderate (4-7)
Swelling
Radiates
Abdomen
Onset
Gradual (days)
Pattern
Constant

Approach

Diagnostic criteria [esd]

  1. Definite: Ravine-Pei criteria with family history and/or proven genetic mutation

  2. Likely: Bilateral enlarged kidneys with >10 cysts and absence of CKD or other cystic disease

  3. Possible: Normally or mildly enlarged kidneys with cysts > 97.5th percentile and absence of CKD or other cystic disease

Ultrasound Criteria for ADPKD: [3et]

Treatment

  1. Non-operative management: [k3e][3et]

    1. Dietary modifications:

      • Three liters of PO fluids daily to suppress vasopressin, thereby decreasing cAMP production and inhibiting cyst production

      • Limit sodium intake to less than 2 grams per day

    2. Control blood pressure: ACEI (enalapril, lisinopril) or ARB (valsartan, telmisartan, losartan, irbesartan, candesartan, olmesartan)

    3. Maintain electrolyte levels: calcium carbonate, calcium acetate, sevelamer, lanthanum carbonate, calcitriol, diuretics

    4. Antibiotics due to kidney cyst infection: ciprofloxacin, ceftriaxone, clindamycin, TMX/SMP

    5. Treat hematuria

    6. Analgesia due to abdominal pain caused by enlarged kidneys

    7. Slow kidney function decline

    8. Hemodialysis/peritoneal dialysis

  2. Surgical intervention:

    1. Surgical drainage of infected cysts: ultrasonography- or CT-guided puncture

    2. Excision/drainage of the outer walls of cysts

    3. Nephrectomy:

      • Severe pain

      • Cyst hemorrhage/hematuria

      • Cyst infection

      • Renal cell carcinoma

      • Calculi in nonfunctioning kidneys with persistent urinary tract infections

      • To increase the abdominal capacity for a future renal transplant

    4. Kidney transplantation

Differential diagnoses

Acute renal failure, Ascites, Bardet-Biedl syndrome, Bladder cancer, Chronic renal failure, Diabetes mellitus, Eclampsia, Heart failure, HIV, Medullary sponge kidney disease, Multiple myeloma, Myocardial infarction, Orofaciodigial syndrome, Ovarian cancer, Preeclampsia, Renal cyst, Renal dysplasia, Rhabdomyolysis, Tuberous sclerosis, Urinary tract infection, Urolithiasis, Von Hippel-Lindau disease


References

[1] Mahboob M, Rout P, Leslie SW, et al. Autosomal Dominant Polycystic Kidney Disease. [Updated 2024 Mar 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532934/

[2] Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, Paterson AD, Pei Y. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. J Am Soc Nephrol. 2018 Oct;29(10):2593-2600.

[3] Willey C, Kamat S, Stellhorn R, Blais J. Analysis of Nationwide Data to Determine the Incidence and Diagnosed Prevalence of Autosomal Dominant Polycystic Kidney Disease in the USA: 2013-2015. Kidney Dis (Basel). 2019 Mar;5(2):107-117.

[4] Suwabe T, Shukoor S, Chamberlain AM, Killian JM, King BF, Edwards M, Senum SR, Madsen CD, Chebib FT, Hogan MC, Cornec-Le Gall E, Harris PC, Torres VE. Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County. Clin J Am Soc Nephrol. 2020 Jan 7;15(1):69-79.

[5] Espinosa Cabello M, Ansio Vázquez I, Espejo Portero I, Rodriguez Fuentes D, Rabasco Ruiz C, Espinosa Hernández M. The natural history of autosomal dominant polycystic kidney disease. A strategy for grouping families and mutations. Nefrologia (Engl Ed). 2023 Jan-Feb;43(1):120-125.

[6] Aung TT, Bhandari SK, Chen Q, Malik FT, Willey CJ, Reynolds K, Jacobsen SJ, Sim JJ. Autosomal Dominant Polycystic Kidney Disease Prevalence among a Racially Diverse United States Population, 2002 through 2018. Kidney360. 2021 Sep 22;2(12):2010-2015.

[7] http://emedicine.medscape.com/article/244907 (2014-01-02); [Medscape]

Scroll to top